$HWAIF

HEALWELL AI (OTCQX: HWAIF) reported peer-reviewed research showing its MyHealth patient app improved user engagement and reduced unnecessary healthcare interactions. The study, published in JMIR, found 65% of users felt more empowered. Additionally, the company's DARWEN™ AI abstract was selected for the HealthAI Global Governance Forum 2026, highlighting its focus on trusted AI governance.

HEALWELL AI, through its subsidiary Intrahealth, has deployed SMART Summary, an AI-powered clinical summarization tool, across New Brunswick. The technology integrates with the Profile EMR platform, reducing clinicians' time on chart review. SMART Summary is now available to 400+ clinicians, with plans for broader adoption. The company is traded on the TSX (AIDX) and OTCQX (HWAIF).

HEALWELL AI (TSX: AIDX) and WELL Health (TSX: WELL) announced that WELLTRUST, a database of consented patients, has surpassed 100,000 consents. HEALWELL's DARWEN AI platform matches trial protocols with this patient population, aiming to streamline clinical trial recruitment. Both companies plan to scale the program, targeting one million consents and international expansion.

HEALWELL AI Inc. (TSX:AIDX, OTCQX:HWAIF) reported Q2-2026 revenue from continuing operations of $33.0 million, roughly flat vs. $33.2 million in Q2-2025. Six-month revenue rose to $66.2 million from $41.2 million, driven by the Orion Health acquisition. Operating cash flow was $4.5 million positive. The company valued its indirect SpaceX stake at about CAD$23 million and targets ~10% Adjusted EBITDA margin by year-end.